Research Article

CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models

Figure 3

CS27109 lessens liver steatosis in HFD rat model: (a) H and E staining of livers among different treating groups after 4-week drug intervention, (b) steatosis, (c) inflammation, (d) ballooning, and (e) NAS scores of liver pathology among different groups. and # represents normal vs. model and drugs vs. model, respectively. , , , , and .
(a)
(b)
(c)
(d)
(e)